Opdivo®

Active substance

 nivolumab

Holder

Bristol-Myres Squibb

Status

Closed 

Indication

 Classical Hodgkin lymphoma in adult patients who have relapsed after ASCT and brentuximab vedotin treatment.

Public documents

Approbation

Information for the patient

Informed consent

Last update

30/01/2017

Last updated on 13/02/2024